Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus (Q38683468)

5 September 2017

title

Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus (English)

1 reference

5 September 2017

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Julie Anh Dung Van

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Anne Lejay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Fei Fang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Meredith Barr

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Fabien Thaveau

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Nabil Chakfe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Bernard Geny

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

James W Scholey

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

21 December 2015

1 reference

Journal of Molecular and Cellular Cardiology

5 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

11-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

Cell biology of ischemia/reperfusion injury

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

State of the science of cardioprotection: Challenges and opportunities--proceedings of the 2010 NHLBI Workshop on Cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Ion transport and energetics during cell death and protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Mitochondria as a drug target in ischemic heart disease and cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Perconditioning and Postconditioning: Current Knowledge, Knowledge Gaps, Barriers to Adoption, and Future Directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The therapeutic potential of ischemic conditioning: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Ischaemic conditioning strategies reduce ischaemia/reperfusion-induced organ injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Regulation of reactive oxygen species generation in cell signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The diabetic heart: too sweet for its own good?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Oxidative stress and myocardial injury in the diabetic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Calcium, ischemia and excitotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Direct detection of endogenous hydroxyl radical production in cultured adult cardiomyocytes during anoxia and reoxygenation. Is the hydroxyl radical really the most damaging radical species?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Removal of H2O2 and generation of superoxide radical: Role of cytochrome c and NADH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The mitochondrion as a key regulator of ischaemic tolerance and injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

TNFalpha and reactive oxygen species in necrotic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Role of reactive oxygen and nitrogen species in the vascular responses to inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The second window of preconditioning (SWOP) where are we now?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Myocardial conditioning: opportunities for clinical translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Nitric oxide in myocardial ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Adenosine receptors and diabetes: Focus on the A(2B) adenosine receptor subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Conditioning the whole heart--not just the cardiomyocyte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Akt protects the heart against ischaemia-reperfusion injury by modulating mitochondrial morphology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Mitochondrial K(ATP) channels in cell survival and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Function of mitochondrial Stat3 in cellular respiration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The SR-mitochondria interaction: a new player in cardiac pathophysiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Role of microtubules in ischemic preconditioning against myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Oxidative stress, diabetes, and diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Oxidative Stress and Diabetic Complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Cytoprotective regulation of the mitochondrial permeability transition pore is impaired in type 2 diabetic Goto-Kakizaki rat hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Inhibition of Na+-H+ exchanger protects diabetic and non-diabetic hearts from ischemic injury: insight into altered susceptibility of diabetic hearts to ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The missing link: a single unifying mechanism for diabetic complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Superoxide activates mitochondrial uncoupling proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Rapid 'glycaemic swings' induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Mitochondria in the diabetic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetic cardiomyopathy: pathophysiology and clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetic cardiomyopathy and its prevention by nrf2: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Role of mitochondria in oxidative stress and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Type 2 diabetes, mitochondrial biology and the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Biochemistry and molecular cell biology of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Impaired cytosolic NADH shuttling and elevated UCP3 contribute to inefficient citric acid cycle flux support of postischemic cardiac work in diabetic hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Cross talk between mitochondria and NADPH oxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Ascorbic acid and N-acetyl cysteine prevent uncoupling of nitric oxide synthase and increase tolerance to ischemia/reperfusion injury in diabetic rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The antioxidant paradox in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

High Glucose Increases Nitric Oxide Synthase Expression and Superoxide Anion Generation in Human Aortic Endothelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Mechanisms involved in attenuated cardio-protective role of ischemic preconditioning in metabolic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Reduction of myocardial infarct size with ischemic "conditioning": physiologic and technical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Ischaemic preconditioning does not protect the heart in obese and lean animal models of Type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Type 2 diabetic obese db/db mice are refractory to myocardial ischaemic post-conditioning in vivo: potential role for Hsp20, F1-ATPase δ and Echs1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Non-invasive limb ischemic pre-conditioning reduces oxidative stress and attenuates myocardium ischemia-reperfusion injury in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetes mellitus and the metabolic syndrome do not abolish, but might reduce, the cardioprotective effect of ischemic postconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Inhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in diabetic hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Differences in myocardial PTEN expression and Akt signalling in type 2 diabetic and nondiabetic patients undergoing coronary bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Preconditioning the diabetic heart: the importance of Akt phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Ginsenoside Rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia/reperfusion injury in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Up-regulation of calcitonin gene-related peptide protects streptozotocin-induced diabetic hearts from ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetes mellitus associated cardiovascular signalling alteration: a need for the revisit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Cardioprotection: chances and challenges of its translation to the clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Ischemic conditioning as an adjunct to percutaneous coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Remote preconditioning and major clinical complications following adult cardiovascular surgery: systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Effect of remote ischemic preconditioning in the elderly patients with coronary artery disease with diabetes mellitus undergoing elective drug-eluting stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Remote ischemic conditioning: evolution of the concept, mechanisms, and clinical application.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.020

10.1016/J.YJMCC.2015.12.020

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26718721%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference